November 3, 2016
Division of Biology Seminar Nov. 4
Jennifer Cameron, assistant professor of microbiology, immunology and parasitology at Louisiana State University Health Sciences Center's Stanley S. Scott Cancer Center, will present "Prescience is bliss: predicting the outcome of low-grade cervical dysplasia to improve clinical management" at 4 p.m. Nov. 4 in 221 Ackert Hall as part of the Division of Biology Seminar Series.
Low-grade dysplasia of the uterine cervix is commonly diagnosed among women undergoing cytologic Pap smear screenings. Two out of every three women with low-grade dysplasia will experience natural resolution of the abnormality without medical intervention within a few years, while the remaining one in three women will progress to high-grade dysplasia and will require medical treatment. Currently, women with low-grade dysplasia are followed clinically with repeat screening tests until resolution or progression of the lesion occurs.
Cameron's research program identifies factors that predict the outcome of low-grade dysplasia at the time of initial diagnosis. Factors that promote resolution of low-grade dysplasia and restoration of cervical health have potential as treatment strategies. Molecular biomarkers that predict the outcome of low-grade cervical dysplasia have potential to be targeted in clinical screening tests to facilitate timely intervention for women who are more likely to progress to high-grade dysplasia.
Cameron will discuss three ongoing projects that are unified around the theme of predicting low-grade dysplasia outcomes with the goal of improving clinical management of this common diagnosis.
If you would like to visit with Cameron, contact Nick Wallace at email@example.com.